Randomized comparison of ranitidine bismuth citrate (RBC)-based triple therapies for H-pylori (HP).

被引:0
|
作者
Laine, L [1 ]
Estrada, R [1 ]
Trujillo, M [1 ]
Emami, S [1 ]
机构
[1] UNIV SO CALIF, SCH MED, LOS ANGELES, CA 90089 USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A192 / A192
页数:1
相关论文
共 50 条
  • [1] Randomized comparison of ranitidine bismuth citrate (RBC)-based triple therapies for H-pylori
    Laine, L
    Estrada, R
    Trujillo, M
    Emami, S
    [J]. GUT, 1997, 41 : A103 - A104
  • [2] Ranitidine bismuth citrate (RBC)-based triple therapies for recurring Helicobacter pylori (Hp) eradication
    Yakovenko, A
    Grigoriev, P
    Yakovenko, E
    Abazova, F
    Poliakov, A
    Agafonova, N
    Pryanishnikova, A
    Chtcherbina, E
    Gulyaev, P
    Gorodinskaya, V
    Avanyan, N
    [J]. GUT, 1999, 45 : A117 - A118
  • [3] Comparison of omeprazole and ranitidine bismuth citrate(RBC)-based triple therapies for the eradication of H.pylori.
    Bardhan, KD
    Morton, D
    Willemse, PJ
    Basu, P
    Perry, MJ
    Rowland, A
    Morris, P
    Thompson, M
    Shaw, C
    Allen, H
    Roberts, PM
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A1214 - A1215
  • [4] A prospective randomized trial of one-week bismuth ranitidine citrate (RBC) triple therapies for H-pylori infection.
    Sung, JJY
    Chan, FKL
    Leung, WK
    Wu, JCY
    Suen, R
    Ling, TKW
    Lee, YT
    Cheng, AFB
    Chung, SCS
    [J]. GASTROENTEROLOGY, 1999, 116 (04) : A321 - A321
  • [5] Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori
    Laine, L
    Estrada, R
    Trujillo, M
    Emami, S
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 1997, 92 (12): : 2213 - 2215
  • [6] The influence of metronidazole (MET) resistance on the efficacy of two triple therapy regimens with ranitidine bismuth citrate (RBC) for H-pylori (Hp) infection
    Van der Wouden, EJ
    Thijs, JC
    van Zwet, AA
    Kooy, A
    Kleibeuker, JH
    [J]. GUT, 1998, 43 : A86 - A86
  • [7] Efficacy of ranitidine bismuth citrate (RBC) dual and triple therapies for the eradication of Helicobacter pylori
    Duggan, A
    Williamson, R
    [J]. GUT, 1998, 42 (04) : 596 - 597
  • [8] Prospective randomized comparisons of ranitidine bismuth citrate (RBC) versus colloidal bismuth subcitrate (Denol)-based triple therapy for the treatment of H-pylori infection.
    Kung, NNS
    Sung, JY
    Yuen, WF
    Li, TH
    Ng, PW
    Lai, WM
    Leung, MF
    [J]. GASTROENTEROLOGY, 1998, 114 (04) : A190 - A190
  • [9] High H-pylori eradication rate with a one week triple regimen containing ranitidine bismuth citrate (RBC)
    Gudjonsson, H
    Bardhan, KD
    Hoie, O
    Kristensen, ES
    Schuetz, E
    KliebeFrisch, C
    Duggan, AE
    [J]. GUT, 1997, 41 : A99 - A99
  • [10] Efficacy of ranitidine bismuth citrate (RBC) dual and triple therapies for the eradication of Helicobacter pylori -: Reply
    Malfertheiner, P
    Mégraud, F
    O'Morain, C
    [J]. GUT, 1998, 42 (04) : 597 - 597